跳到正文
原文
Medical Xpress·· 29 天前AI 评分46

小鼠模型中 Cas9 nickase 介导的 CAG/CTG 重复序列缩短改善亨廷顿病表型

New gene-editing approach shows promise in treating Huntington's disease in mice

AI 导读

Cardiff 大学研究团队在 Science Translational Medicine 发表预印本研究,利用 Cas9 nickase 在小鼠亨廷顿病模型中缩短 CAG/CTG 重复序列。

正文
gene-editing
Credit: Unsplash/CC0 Public Domain

Huntington's disease is caused by repetitive "stutters" in DNA—specifically repeated CAG sequences—that expand abnormally over time, leading to toxic protein accumulation that contributes to the progression of the disease. There is currently no cure for this rare and fatal genetic disease.

Professor Vincent Dion of the UK Dementia Research Institute at Cardiff University, who led the research team, said, "The length of these repeated sequences accounts for most of the variation in how severe the disease is, so targeting and reducing these sequences is a potentially viable therapeutic avenue.

"Traditional gene-editing techniques often cut both strands of DNA to disable mutated genes, but this can trigger unpredictable rearrangements, off-target mutations or damage to healthy copies of the gene. Some researchers are also trying to apply these traditional gene-editing techniques to treating Huntington's disease in preclinical work, but they have limitations."

"We wanted to finesse this technique to explore whether there are more reliable potential genetic treatments for Huntington's disease."

Single-strand cuts shorten DNA repeats

In the new study, published in Science Translational Medicine, researchers used a more precise gene-editing enzyme called Cas9 nickase, which cuts only a single strand of DNA within the repeated CAG/CTG sequences in mouse models of Huntington's disease.

Professor Dion said, "When packaged into viral vectors and delivered directly to the striatum—the brain region primarily impacted by Huntington's disease—in a mouse model, the therapy shortened the DNA repeats in the majority of targeted neurons.

"This led to fewer toxic huntingtin protein aggregates, restored healthier gene expression pathways in brain cells and showed significant improvements in motor function during locomotion tests."

The team says no unwanted mutations were detected in brain cells in the mouse models with this approach, and it offers a potentially safer alternative to conventional gene-editing methods.

Further testing before human trials

"While much more research is needed—and our results only apply to mouse models of Huntington's—these are exciting findings because there is currently no treatment for Huntington's disease that changes the course of the disease. This could represent a novel therapeutic pathway through which we may be able to prevent the progression of—or effectively treat—Huntington's disease."

The research was based on the CRISPR gene-editing method and has potential application beyond Huntington's disease in other genetic diseases caused by expanded repetitions in genetic codes.

Now, the team says more research is needed to optimize delivery methods to ensure stable, long-term expression of the editing tools without triggering immune responses, investigate whether treating animals at earlier stages can prevent neurodegenerative damage before symptoms ever appear, and conduct rigorous safety and efficiency testing in larger preclinical models to build the foundation for human clinical trials.

Publication details

Alvaro Murillo et al., Cas9 nickase–mediated contraction of CAG/CTG repeats is associated with phenotypic improvements in a Huntington's disease mouse model, Science Translational Medicine (2026). DOI: 10.1126/scitranslmed.aef9466

Journal information: Science Translational Medicine

Who's behind this story?

Sadie Harley

Sadie Harley

BSc Life Sciences & Ecology. Microbiology lab background with pharmaceutical news experience in oil, gas, and renewable industries. Full profile →

Robert Egan

Robert Egan

Bachelor's in mathematical biology, Master's in creative writing. Well-traveled with unique perspectives on science and language. Full profile →

Citation: New gene-editing approach shows promise in treating Huntington's disease in mice (2026, October 22) retrieved 22 October 2026 from https://medicalxpress.com/news/2026-10-gene-approach-huntington-disease-mice.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

来源:Medical Xpress · medicalxpress.com